Research Article
Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
Table 1
Patient demographics (
patients).
| | Tumor characteristics | Stage I | Stage II |
| | Number of patients | 28 (33.3%) | 56 (66.7%) | | Mean age (years) | 51.07 (±10.6) | 53.40 (±13.5) | | Sex | | | | Female (%) | 17 (60.7%) | 37 (66.1%) | | Male (%) | 11 (39.3%) | 19 (33.9%) | Mean Breslow depth (mm)
Minimum/maximum | 1.42 (±1.1)
0.22 mm | 3.29 (±1.7)
12 mm | | Localization | | | | Head/neck (%) | 3 (10.7%) | 4 (7.1%) | | Trunk (%) | 12 (42.9%) | 35 (62.5%) | | Extremity (%) | 13 (46.4%) | 17 (30.4%) |
|
|
